{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:12Z","timestamp":1707524592304},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,16]]},"DOI":"10.7759\/cureus.23207","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T10:02:58Z","timestamp":1647424978000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Hemolytic Uremic Syndrome Caused by a Rare Complement Factor B Mutation"],"prefix":"10.7759","author":[{"given":"Sai Samyuktha","family":"Bandaru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma LM","year":"2021","unstructured":"Palma LM, Sridharan M, Sethi S. Complement in secondary thrombotic microangiopathy. Kidney Int Rep. 2021, 6:11-23. 10.1016\/j.ekir.2020.10.009","journal-title":"Kidney Int Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e3283378f25","article-title":"Thrombotic microangiopathy: new insights","volume":"19","author":"Benz K","year":"2010","unstructured":"Benz K, Amann K. Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens. 2010, 19:242-7. 10.1097\/MNH.0b013e3283378f25","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge E","year":"2007","unstructured":"Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, et al.. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A. 2007, 104:240-5. 10.1073\/pnas.0603420103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris M","year":"2005","unstructured":"Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005, 16:1035-50. 10.1681\/ASN.2004100861","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-016-0357-7","article-title":"Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab","volume":"30","author":"Asif A","year":"2017","unstructured":"Asif A, Nayer A, Haas CS. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol. 2017, 30:347-62. 10.1007\/s40620-016-0357-7","journal-title":"J Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-0872-4","article-title":"Complement and the atypical hemolytic uremic syndrome in children","volume":"23","author":"Loirat C","year":"2008","unstructured":"Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2008, 23:1957-72. 10.1007\/s00467-008-0872-4","journal-title":"Pediatr Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore I","year":"2010","unstructured":"Moore I, Strain L, Pappworth I, et al.. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010, 115:379-87. 10.1182\/blood-2009-05-221549","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000445127","article-title":"Comprehensive analysis of complement genes in patients with atypical hemolytic uremic syndrome","volume":"43","author":"Zhang T","year":"2016","unstructured":"Zhang T, Lu J, Liang S, et al.. Comprehensive analysis of complement genes in patients with atypical hemolytic uremic syndrome. Am J Nephrol. 2016, 43:160-9. 10.1159\/000445127","journal-title":"Am J Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025069","article-title":"Atypical hemolytic uremic syndrome and acute tubular necrosis induced by complement factor B gene (CFB) mutation: a case report","volume":"100","author":"Wu H","year":"2021","unstructured":"Wu H, Su S, Li L, Zhang L. Atypical hemolytic uremic syndrome and acute tubular necrosis induced by complement factor B gene (CFB) mutation: a case report. Medicine (Baltimore). 2021, 100:e25069. 10.1097\/MD.0000000000025069","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque AL","year":"2011","unstructured":"Lapeyraque AL, Malina M, Fremeaux-Bacchi V, et al.. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med. 2011, 364:2561-3. 10.1056\/NEJMc1100859","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfx081","article-title":"Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea","volume":"10","author":"Brocklebank V","year":"2017","unstructured":"Brocklebank V, Kavanagh D. Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea. Clin Kidney J. 2017, 10:600-24. 10.1093\/ckj\/sfx081","journal-title":"Clin Kidney J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"N\u00fcrnberger J","year":"2009","unstructured":"N\u00fcrnberger J, Philipp T, Witzke O, et al.. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med. 2009, 360:542-4. 10.1056\/NEJMc0808527","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/68600-atypical-hemolytic-uremic-syndrome-caused-by-a-rare-complement-factor-b-mutation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:47Z","timestamp":1707507347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/68600-atypical-hemolytic-uremic-syndrome-caused-by-a-rare-complement-factor-b-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.23207","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}